Paul Tudor Jones Royalty Pharma PLC Transaction History
Tudor Investment Corp Et Al
- $19.2 Billion
- Q2 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Royalty Pharma PLC stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 312,500 shares of RPRX stock, worth $8.81 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
312,500
Previous 16,048
1847.28%
Holding current value
$8.81 Million
Previous $487,000
1591.99%
% of portfolio
0.04%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding RPRX
# of Institutions
398Shares Held
291MCall Options Held
305KPut Options Held
138K-
Morgan Stanley New York, NY44.1MShares$1.24 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA38MShares$1.07 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$649 Million0.01% of portfolio
-
Baillie Gifford & CO16.4MShares$461 Million0.34% of portfolio
-
Viking Global Investors LP12MShares$337 Million1.26% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $12.3B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...